Program

Scientific program is subject to change. The program will be updated regularly as speakers are confirmed and learning objectives are received.

All content for the conference will be available approximately one week prior to the start of the conference, to registered participants, by clicking on the "Access Content" tab of this website. *Please allow 24 hours following your registration to activate the access.

Printable program at-a-glance

_
Room Name: Exhibit hall

Breakfast and exhibits

07:00 AM to 07:45 AM
Room Name: Toronto I&II

Welcome message

08:00 AM to 08:15 AM
Room Name: Toronto I&II

President's lecture -
Universal contraception: An irresistible policy

08:15 AM to 08:45 AM

Session Details

At the end of this session, participants will be able to:
  • Understand the rationale for a universal contraception coverage policy;
  • Recognize what is currently being done;
  • Implement strategies to achieve universal contraception policies.
Speakers:
Room Name: Toronto I&II

Guideline No. 441 -
Antenatal fetal health surveillance

08:45 AM to 09:30 AM

Session Details

At the end of this session, participants will be able to:
  • Discuss the latest evidence regarding antenatal assessment tests;
  • List key changes in the 2023 CPG Antenatal Fetal Health Surveillance Guideline;
  • Identify the appropriate use and timing of antenatal fetal health surveillance assessments in light of the total clinical picture;
  • Use defined terminology correctly.
Speakers:
Room Name: Toronto I&II

Primary dysmenorrhea

09:30 AM to 10:15 AM

Session Details

At the end of this session, participants will be able to:
  • Actively screen patients for symptoms of primary dysmenorrhea ;
  • Offer evidence-based treatment options using a patient-centered approach ;
  • Provide close follow up to ensure that medical regimens are maximized;
  • Commit to working with the patient to improve her quality of life and to minimize short-term and long-term morbidity.
Speakers:
Room Name: Exhibit hall

Networking break and exhibits

10:15 AM to 10:45 AM
Room Name: Toronto I&II

Taking care of ourselves when providing trauma informed care

10:45 AM to 11:15 AM

Session Details

At the end of this session, participants will be able to:
  • Explore how to make meaning of our work with traumatized patients, in order to proactively manage our own well-being;
  • Discuss how we can integrate collective care into our work, moving beyond relying on the concept of self-care;
  • Consider how engaging in trauma-informed care can help prevent the symptoms of vicarious trauma and secondary traumatic stress.
Speakers:
Room Name: Toronto I&II

Enhanced Recovery After Surgery (ERAS):
Cesarean delivery

11:15 AM to 12:00 PM

Session Details

At the end of this session, participants will be able to:
  • Discuss the rationale of ERAS, components of ERAS, and how it applies to cesarean delivery;
  • Adopt ERAS for Cesarean; introduction of the new guideline;
  • Measure success.
Speakers:
Room Name: Exhibit hall

Lunch and exhibits

12:00 PM to 12:45 PM
Room Name: Toronto I&II

Preeclampsia risk prediction and diagnosis:
Lessons learned through clinical implementation

12:45 PM to 01:30 PM

Session Details

At the end of this session, participants will be able to:
  • Understand different risk calculation models of preeclampsia during the course of the pregnancy;
  • Describe the circulating biomarkers, various laboratory assays and their clinical applications in preeclampsia;
  • Explain the feasibility and acceptability of implementing multiple markers preeclampsia prediction at the time of aneuploidy screening in a tertiary level centre in Toronto.
  • Explain the clinical validation in implementing sFlt-1:PlGF ratio in the laboratory for preeclampsia diagnosis.
Speakers:
Room Name: Toronto I&II

Fetal growth restriction:
Screening, diagnosis and management in singleton pregnancies

01:30 PM to 02:15 PM

Session Details

At the end of this session, participants will be able to:
  • Analyze key updates of the 2023 SOGC Fetal Growth Restriction Guideline using a case based approach;
  • Understand the interpretation and management of fetal Doppler studies, including the application Cerebro-Placental Ratio [CPR];
  • Identify laboratory tests – old and new - that may be useful in evaluating pregnancies affected by Fetal Growth Restriction;
  • Apply new key concepts to work through two cases.
Speakers:
Room Name: Exhibit hall

Networking break and exhibits

02:15 PM to 02:45 PM
Room Name: Toronto I&II

Concurrent session -
Endometrial thickness and polyps: In a nutshell

02:45 PM to 03:45 PM

Session Details

At the end of this session, participants will be able to:
  • Review the pathophysiology and prevalence of endometrial polyps;
  • Define asymptomatic endometrial thickness in postmenopausal females;
  • Critically appraise the evidence regrading risk factors for malignancy in endometrial polyps and asymptomatic endometrial thickness and evaluate when treatment is indicated;
  • Create a framework for effective management strategies for each individualized patient.
Speakers:
Room Name: Tom Thomson

Concurrent session -
The prevention of early-onset neonatal GBS disease/management of GBS bacteriuria in pregnancy

02:45 PM to 03:45 PM

Session Details

At the end of this session, participants will be able to:
  • Define and manage asymptomatic bacteriuria in pregnancy;
  • Describe the incidence of early-onset Group B Streptococcus (GBS) disease in newborns;
  • Discuss the approach to reduce early-onset GBS disease in newborns;
  • Provide appropriate intrapartum antibiotic prophylaxis to women colonized with GBS who have an allergy to penicillin.
Speakers:
Room Name: Carmichael/ Jackson

Concurrent session -
Guideline No. 445 - Management of chronic pelvic pain

02:45 PM to 03:45 PM

Session Details

At the end of this session, participants will be able to:
  • Describe an approach to evaluating patients with chronic pelvic pain;
  • Develop a plan to triage patients requiring medical versus surgical for chronic pelvic pain;
  • Develop a simple systematic plan for managing patients with chronic pelvic pain.
Speakers:
Room Name: Harris/ Macdonald

Concurrent session -
Multifetal pregnancy reduction

02:45 PM to 03:45 PM

Session Details

At the end of this session, participants will be able to:
  • Identify pregnancy management options related to number of fetuses that need consideration during antenatal care for a multifetal gestation;
  • Outline fetal reduction options and associated risks;
  • Formulate a management plan based on the pregnant person's choice.
Speakers:
Room Name: Toronto I&II

Guideline No. 444 -
Hirsutism: Evaluation and treatment

03:50 PM to 04:35 PM

Session Details

At the end of this session, participants should be able to:
  • Perform an appropriate physical examination for a patient presenting with hirsutism;
  • Order appropriate testing for a patient presenting with hirsutism;
  • Counsel a patient presenting with hirsutism regarding treatment options, including physical hair removal options and medical therapy.
    • Speakers:
    Room Name: Toronto I&II

    OSOG/SOGC Awards

    04:35 PM to 05:15 PM
    Room Name: Exhibit hall

    Reception

    05:15 PM to 06:00 PM

    No content found

    No content found

    No content found